Guthaus, E;Schmiedeberg, N;Bürgle, M;Magdolen, V;Kessler, H;Schmitt, M
The urokinase receptor (uPAR, CD87) as a target for tumor therapy: uPA-silica particles (SP-uPA) as a new tool for assessing synthetic peptides to interfere with uPA/uPA-receptor interaction.
Recent Results Cancer Res
2003
162
3-14

Harbeck, N;Thomssen, C
[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast]
Zentralbl Gynakol
2003
125
9
362-7

Harbeck, N
[Adjuvant chemotherapy in primary carcinoma of the breast]
Zentralbl Gynakol
2003
125
9
322-6

Roggel, F;Hocke, S;Lindemann, K;Sinz, S;Welk, A;Bösl, M;Pabst, M;Nusser, N;Braun, S;Schmitt, M;Harbeck, N
Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.
Recent Results Cancer Res
2003
162
89-100

Schneeweiss, A;Thomssen, Ch;Harbeck, N;Bastert, G
[Prognostic factors in carcinoma of the breast. Thereupon depends success of the treatment]
MMW Fortschr Med
2003
145
24
34-6, 38

Harbeck, N
[Interview with private lecturer Dr. med. Nadia Harbeck, Munich. Prognostic markers guide therapy (interview by Jochen Aumiller)]
MMW Fortschr Med
2003
145
3-4
8, 10

Schmutzler, R;Schlegelberger, B;Meindl, A;Gerber, WD;Kiechle, M
[Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD]
Zentralbl Gynakol
2003
125
12
494-506

Mettler, L;Audebert, A;Lehmann-Willenbrock, E;Jacobs, VR;Schive, K
New adhesion prevention concept in gynecological surgery.
JSLS
2003
7
3
207-9

Paepke, S;V Minckwitz, G;Kaufmann, M;Schwarz-Boeger, U;Jacobs, VR;Aigner, M;Pfeifer, K;Ehmer, M;Hüttner, C;Blohmer, JU;Kiechle, M
[Chemoprevention of breast cancer: a literature review and report on the current status in Germany]
Zentralbl Gynakol
2003
125
9
338-45

Morrison, JE;Jacobs, VR
Reduction or elimination of postoperative pain medication after mastectomy through use of a temporarily placed local anesthetic pump vs. control group.
Zentralbl Gynakol
2003
125
1
17-22